---
title: "Hypertension Control and Cardiovascular Mortality"
subtitle: "Projected Health Outcomes Under WHO HTN Target Scenarios, 2026--2050"
author: "David Watkins, William Garcia and Kouamivi Agboyibor"
institute: "University of Washington $\\cdot$ WHO"
date: "`r format(Sys.Date(), '%B %Y')`"
output:
  beamer_presentation:
    keep_tex: false
    latex_engine: xelatex
    slide_level: 2
    toc: true
    includes:
      in_header: beamer_preamble.tex
classoption: "aspectratio=169"
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(
  echo      = FALSE,
  message   = FALSE,
  warning   = FALSE,
  fig.align = "center",
  fig.height = 3.4,
  fig.width  = 8.5,
  out.width  = "\\linewidth",
  dev = "cairo_pdf"
)
```

```{r libraries}
library(data.table)
library(knitr)
library(kableExtra)
library(scales)
library(ggplot2)
```

```{r paths}
# ── Single path definition: all pre-computed objects live here ─────────────────
# This must match wd_outp in aim2_report.Rmd.
wd_outp <- "C:/Users/wrgar/OneDrive - UW/02Work/WHO-CVD/github/uw-who-cvdtargets/output/"
```

```{r helpers}
# ── Formatting helpers only — no data manipulation ────────────────────────────
fmt_m <- function(x, digits = 1)
  formatC(round(x / 1e6, digits), format = "f", digits = digits, big.mark = ",")
fmt_k <- function(x, digits = 0)
  formatC(round(x / 1e3, digits), format = "f", digits = digits, big.mark = ",")

# ── Shared aesthetics (needed for static tables in this deck) ─────────────────
htn_cols <- c(
  "b.a.u"        = "#999999",
  "Progress"     = "#74c476",
  "Ambitious"    = "#2171b5",
  "Aspirational" = "#6a3d9a"
)
htn_scenarios <- c("Progress", "Ambitious", "Aspirational")
```

```{r load-precomputed}
# ── Load all pre-computed objects produced by aim2_report.Rmd ─────────────────
# If any file is missing, knit aim2_report.Rmd first to generate them.

slides_scalars <- readRDS(paste0(wd_outp, "aim2_slides_scalars.rds"))
dt_annual      <- readRDS(paste0(wd_outp, "aim2_slides_annual.rds"))
dt_sl_tab1     <- readRDS(paste0(wd_outp, "aim2_slides_tab1_summary.rds"))
dt_sl_tab5     <- readRDS(paste0(wd_outp, "aim2_slides_tab5_region.rds"))
dt_top20       <- readRDS(paste0(wd_outp, "aim2_slides_top20.rds"))
dt_age_sex     <- readRDS(paste0(wd_outp, "aim2_slides_age_sex.rds"))

# ── Unpack scalars into bare names used throughout the deck ───────────────────
n_countries        <- slides_scalars$n_countries
total_progress     <- slides_scalars$total_progress
total_ambitious    <- slides_scalars$total_ambitious
total_aspirational <- slides_scalars$total_aspirational
bau_total          <- slides_scalars$bau_total_deaths
```

<!-- ============================================================ -->
<!-- TITLE FRAME is auto-generated by Beamer from YAML            -->
<!-- ============================================================ -->

# \textcolor{uwpurple}{Project Context}

## The UW -- WHO CVD Targets 2030 Project

\begin{columns}[T]
\begin{column}{0.55\textwidth}
\textbf{Modelling the Burden of Disease Impact of\\Cardiovascular Risk-Factor Control}

\medskip
Evaluates the population-health impact of achieving four WHO CVD risk-factor targets by 2030, endorsed in the \textbf{2025 NCD Political Declaration}:

\begin{itemize}
  \item \textbf{150 million} more people with hypertension under control
  \item $\geq$\textbf{50\%} of eligible individuals receiving lipid-lowering therapy and counselling
  \item \textbf{80\%} BP control among people with diagnosed diabetes
  \item \textbf{80\%} availability of validated automated BP devices
\end{itemize}
\end{column}

\begin{column}{0.42\textwidth}
\begin{block}{Two Companion Scientific Outputs}
\small
\textbf{Aim 1.} Projected Health Outcomes of Achieving WHO Targets for CVD Risk-Factor Control: A Modelling Study

\medskip
\textcolor{blue}{\textbf{Aim 2.} How Increasing National BP Control Contributes to the WHO 150-Million Target by 2030}
\end{block}

\begin{alertblock}{This Presentation}
\small
Focuses exclusively on \textbf{Aim 2}: HTN control scenarios and their projected CVD mortality impact (2026--2050).
\end{alertblock}
\end{column}
\end{columns}

## The CVD Burden Is Growing --- and Largely Preventable

\begin{columns}[T]
\begin{column}{0.54\textwidth}
\textbf{Cardiovascular disease kills $\sim$20 million people per year}

\medskip
\begin{itemize}
  \item Leading cause of death in every world region
  \item Four causes modelled jointly:
  \begin{itemize}
    \item Ischemic heart disease (IHD)
    \item Ischemic stroke
    \item Intracerebral hemorrhage
    \item Hypertensive heart disease (HHD)
  \end{itemize}
  \item \textbf{Hypertension} is the single largest modifiable CVD risk factor
  \item $\sim$1.28 billion adults affected; only 1 in 5 have BP under control
\end{itemize}
\end{column}

\begin{column}{0.43\textwidth}
\begin{exampleblock}{Why HTN Control? Why Now?}
\small
\begin{tabular}{@{}ll@{}}
Prevalence   & $\sim$31\% of adults globally \\
Treated      & $<$50\% diagnosed \\
Controlled   & $<$20\% at BP target \\
WHO target   & 80\% control by 2030 \\
Cost-eff.    & Highest-value NCD action \\
Policy window & 2025 NCD Declaration \\
\end{tabular}
\end{exampleblock}

\begin{block}{Definition}
\small
\textbf{HTN control}: sustained BP $<$140/90 mmHg among treated hypertensive individuals
\end{block}
\end{column}
\end{columns}

# \textcolor{uwpurple}{Study Overview --- Aim 2}

## Aim 2: Research Questions

\begin{block}{Central Question}
How many cardiovascular deaths could be averted between \textbf{2026 and 2050} if countries achieve Progress, \textbf{Ambitious}, or Aspirational hypertension control targets by 2030?
\end{block}

\medskip
\textbf{Sub-questions driving the analysis:}

\begin{enumerate}
  \item Which \textbf{causes} of CVD death benefit most from HTN control scale-up?
  \item Which \textbf{regions} stand to gain the most?
  \item How do gains \textbf{accumulate over time} --- and when do they begin?
  \item How does benefit vary by \textbf{age and sex}?
\end{enumerate}

\medskip
\begin{columns}[T]
\begin{column}{0.48\textwidth}
\begin{exampleblock}{Scope}
\small
\textbf{`r n_countries` countries} $\cdot$ Ages 20--95 $\cdot$ 2026--2050 $\cdot$ 4 CVD causes
\end{exampleblock}
\end{column}
\begin{column}{0.48\textwidth}
\begin{alertblock}{Intervention start: 2026}
\small
Model calibrated from 2019. First year of HTN scale-up effects entering the projection is \textbf{2026}.
\end{alertblock}
\end{column}
\end{columns}

## Study Design at a Glance

```{r design-table}
design <- data.table(
  Component = c("Model type","Calibration data","Population data",
                "Intervention start","Scale-up period","Comparison",
                "Outcome","Time horizon"),
  Detail = c(
    "Discrete-time multi-state model (Well $\\to$ Sick $\\to$ Dead)",
    "GBD 2023: incidence, case fatality, prevalence; all-cause \\& CVD-specific",
    "UNWPP 2024 single-year age/sex projections",
    "\\textbf{2026} --- first year intervention effects enter the projection",
    "Linear scale-up 2026 $\\to$ 2030; rates held constant 2030--2050",
    "Business-as-usual: 2024 control rates, no additional scale-up",
    "CVD deaths averted vs.~BAU; age-standardised mortality rate (ASMR)",
    "2026--2050 (25-year horizon); model calibrated from 2019"
  )
)
kable(design, col.names=c("Component","Detail"),
      align="ll", escape=FALSE, booktabs=TRUE, format="latex") |>
  kable_styling(latex_options=c("striped","hold_position"),
                font_size=8, full_width=TRUE) |>
  column_spec(1, bold=TRUE, width="3.2cm") |>
  column_spec(2, width="9.8cm") |>
  row_spec(4, background="#dbeafe")
```

# \textcolor{uwpurple}{Data Sources}

## Data Sources and Key Variables

```{r data-sources-table}
ds <- data.table(
  Source    = c("GBD 2023 (IHME)","GBD 2019 (IHME)","Ettehad et al.\\ 2016",
                "UNWPP 2024 (UN)","WHO / NCD-RisC","Country-specific"),
  Variables = c(
    "IR, CF, prevalence, background mortality (age/sex/country)",
    "Relative risks per 10 mmHg SBP increase (IHD, stroke, HHD, by age)",
    "Trial effect sizes per BP category; diabetes-stratified",
    "Population projections 2019--2050 (single-year age, sex, country)",
    "Baseline HTN control rates ($C_0$); BP distribution by country",
    "HTN control targets 2030 (Progress / Ambitious / Aspirational)"
  ),
  Role = c(
    "Baseline transition rates; initial states",
    "Anchor BP-bin incidence; normalisation factor $\\alpha$",
    "Treatment effect sizes by BP bin $\\times$ cause",
    "Cohort sizes; rate denominators",
    "$C_0$; $P(\\text{BP}_{\\text{cat}})$",
    "$C_{\\text{target}}$ per scenario"
  )
)
kable(ds, align="lll", escape=FALSE, booktabs=TRUE, format="latex",
      col.names=c("Source","Variables extracted","Role in model")) |>
  kable_styling(latex_options=c("striped","hold_position"),
                font_size=8, full_width=TRUE) |>
  column_spec(1, bold=TRUE, width="2.8cm") |>
  column_spec(2, width="6.8cm") |>
  column_spec(3, width="3.4cm")
```

# \textcolor{uwpurple}{Scenarios}

## Three HTN Target Scenarios

\begin{columns}[T]
\begin{column}{0.44\textwidth}
\textbf{All scenarios share:}
\begin{itemize}\small
  \item Same GBD-calibrated baseline transition rates
  \item Same baseline BP distributions (2019)
  \item Linear scale-up \textbf{2026 $\to$ 2030}
  \item Rates held constant after 2030
  \item Coverage applied to hypertensive bins only ($\geq$140 mmHg)
\end{itemize}

\medskip
\textbf{They differ only in the target control rate by 2030.}

\medskip
\textbf{Scale-up rule:}
$$C_t = C_0 + \Delta C^* \cdot \min\!\left(\frac{t - 2026}{2030 - 2026},\;1\right)$$
\end{column}

\begin{column}{0.53\textwidth}
\small
\begin{block}{\colorbox{baugrey}{\textcolor{white}{Business-as-Usual (BAU)}}}
\small No additional scale-up; 2024 control rates maintained.
\end{block}

\begin{block}{\colorbox{progressgreen}{\textcolor{white}{Progress}}}
\small Continuation of recent trends in control through 2030.
\end{block}

\begin{block}{\hlambitious{Ambitious} \textnormal{--- \textit{headline scenario}}}
\small \textbf{Accelerated scale-up} toward WHO interim targets. Most credible policy-stretch goal for 2030 and the basis for the WHO 150-million commitment.
\end{block}

\begin{block}{\colorbox{aspirationalpurple}{\textcolor{white}{Aspirational}}}
\small \textbf{Full achievement} of WHO 2030 HTN targets 50\% --- upper bound estimate.
\end{block}
\end{column}
\end{columns}

## HTN Control Targets by 2030 --- Country Distribution

```{r scenario-targets-plot, fig.height=2.9}
dt_hbp_targets <- tryCatch(
  fread(paste0(wd_data,"htn_control_targets_by_loc.csv")),
  error=function(e) NULL
)
if (!is.null(dt_hbp_targets)) {
  dt_long <- melt(dt_hbp_targets,
    id.vars="location",
    measure.vars=c("htncov2_progress","htncov2_ambitious","htncov2_aspirational"),
    variable.name="target_col", value.name="target_value")
  dt_long[, scenario_lbl := factor(htn_labels[target_col],
                                   levels=c("Progress","Ambitious","Aspirational"))]
  ggplot(dt_long, aes(x=scenario_lbl, y=target_value*100, fill=scenario_lbl)) +
    geom_boxplot(alpha=0.75, outlier.size=1, width=0.45) +
    annotate("rect", xmin=1.5, xmax=2.5, ymin=0, ymax=100,
             fill="#2171b5", alpha=0.07) +
    annotate("text", x=2, y=97,
             label="Headline scenario", size=3,
             color="#2171b5", fontface="bold") +
    scale_fill_manual(values=htn_cols[c("Progress","Ambitious","Aspirational")],
                      guide="none") +
    scale_y_continuous(limits=c(0,100), expand=c(0,0)) +
    labs(title="Distribution of Country-Level HTN Control Targets by 2030",
         subtitle="Each box = distribution across countries | scale-up starts 2026",
         x=NULL, y="HTN Control Rate (%)") +
    theme_minimal(base_size=11) +
    theme(plot.title=element_text(face="bold"), panel.grid.minor=element_blank())
} else {
  ggplot() + annotate("text",x=0.5,y=0.5,
    label="[Figure: HTN target distribution -- data pending]",
    size=5,color="grey60") + theme_void()
}
```

# \textcolor{uwpurple}{Mathematical Model}

## Model Architecture: Three Health States

```{r state-diagram, fig.height=2.7}
nodes <- data.table(
  x=c(1,3.2,5.4), y=c(1,1,1),
  label=c("Well\n(W)","Sick\n(K)","Dead\n(D)"),
  fill=c("#d4edda","#fff3cd","#f8d7da")
)
arr_main <- data.table(
  x1=c(1.40,3.60), y1=c(1,1), x2=c(2.80,5.00), y2=c(1,1),
  lbl=c("IR \u00d7 \u03b5_IR","CF \u00d7 \u03b5_CF")
)
arr_bg <- data.table(
  x1=c(1.0,3.2,3.0), y1=c(1.25,1.25,1.0),
  x2=c(1.0,3.2,5.0), y2=c(0.62,0.62,0.62),
  lbl=c("BG.mx","BG.mx","BG.mx.all")
)
ggplot() +
  geom_tile(data=nodes, aes(x=x,y=y,fill=fill),
            width=0.75,height=0.42,color="grey30",linewidth=0.8) +
  scale_fill_identity() +
  geom_text(data=nodes, aes(x=x,y=y,label=label), size=4, fontface="bold") +
  geom_segment(data=arr_main,
    aes(x=x1,y=y1,xend=x2,yend=y2),
    arrow=arrow(length=unit(0.22,"cm"),type="closed"),
    linewidth=1.2, color="#2171b5") +
  geom_label(data=arr_main,
    aes(x=(x1+x2)/2, y=y1+0.22, label=lbl),
    size=3.2, fill="white", label.padding=unit(0.12,"cm"), color="#2171b5") +
  geom_segment(data=arr_bg,
    aes(x=x1,y=y1,xend=x2,yend=y2),
    arrow=arrow(length=unit(0.16,"cm"),type="closed"),
    linewidth=0.7, color="grey55", linetype="dashed") +
  geom_label(data=arr_bg,
    aes(x=(x1+x2)/2+0.2, y=(y1+y2)/2, label=lbl),
    size=2.6, fill="white", color="grey50", label.padding=unit(0.08,"cm")) +
  scale_x_continuous(limits=c(0.5,6.0)) +
  scale_y_continuous(limits=c(0.28,1.58)) +
  theme_void(base_size=11) +
  labs(title="Multi-State Transition Model  |  Annual time step  |  Ages 20-95  |  4 CVD causes")
```

\small \textbf{Key:} $\varepsilon_{IR}$, $\varepsilon_{CF}$ = multiplicative effect ratios from the intervention module $\cdot$ BG.mx = background mortality $\cdot$ COVID-19 excess mortality applied 2020--2021 only

## Intervention Module: 9-Step Pipeline

```{r steps-table}
steps <- data.table(
  Step=paste0(1:9),
  Action=c(
    "Baseline BP distribution $P(\\text{BP}_{\\text{cat}})$ without treatment (rx$\\,=\\,0$)",
    "GBD relative risks per 10 mmHg SBP $\\to$ bin-specific incidence $IR_{\\text{bin}}$",
    "Diabetes-weighted Ettehad trial effect sizes $E_{\\text{trial}}$ per BP bin $\\times$ cause",
    "Linear coverage scale-up from $C_0$ to $C_{\\text{target}}$, \\textbf{starting 2026}",
    "Coverage adjustment: $E_{\\text{adj}} = E_{\\text{trial}}(C_t - C_0)\\,/\\,(1 - E_{\\text{trial}}\\,C_0)$",
    "New bin incidence: $IR_{\\text{bin,new}} = IR_{\\text{bin}} \\times (1 - E_{\\text{adj}})$",
    "Aggregate: $IR_{\\text{new}} = \\sum IR_{\\text{bin,new}} \\times P(\\text{BP}_{\\text{cat}})$",
    "Incidence effect ratio: $\\varepsilon_{IR} = IR_{\\text{new}}\\,/\\,IR_{\\text{original}}$",
    "Case-fatality effect ratio: $\\varepsilon_{CF} = 1 - \\rho_{CF} \\times C_{\\text{agg}}^{\\Delta}$"
  ),
  Output=c(
    "$P(\\text{BP}_{\\text{cat}}\\,|\\,a,s,t)$",
    "$IR_{\\text{bin}}$","$E_{\\text{trial}}$",
    "$C_t(t,\\,\\text{BP}_{\\text{cat}})$","$E_{\\text{adj}}(t)$",
    "$IR_{\\text{bin,new}}$","$IR_{\\text{new}}$",
    "$\\varepsilon_{IR}\\to$ model","$\\varepsilon_{CF}\\to$ model"
  )
)
kable(steps, col.names=c("","Action","Output"),
      align="cll", escape=FALSE, booktabs=TRUE, format="latex") |>
  kable_styling(latex_options=c("striped","hold_position"),
                font_size=7.5, full_width=TRUE) |>
  column_spec(1, bold=TRUE, width="0.5cm") |>
  column_spec(2, width="9.5cm") |>
  column_spec(3, italic=TRUE, width="2.8cm") |>
  row_spec(c(8,9), background="#d4edda") |>
  row_spec(4, background="#dbeafe")
```

\small\textit{Blue row = intervention start (2026). Green rows = outputs passed to state-transition model.}

## Key Equations

\begin{columns}[T]
\begin{column}{0.48\textwidth}
\textbf{Incidence pathway}

\medskip
\textit{Step 2 --- GBD RR anchors bin incidence:}
$$IR_{\text{bin}} = \frac{RR_{\text{GBD}} \times IR}{\alpha},\quad \alpha = \sum_{\text{cat}} P_{\text{cat}}\cdot RR_{\text{GBD}}$$

\textit{Step 5 --- baseline-adjusted effect (no double-counting):}
$$E_{\text{adj}}(t) = \frac{E_{\text{trial}}\,(C_t - C_0)}{1 - E_{\text{trial}}\,C_0}$$

\textit{Steps 7--8 --- population-weighted effect ratio:}
$$\varepsilon_{IR} = \frac{\sum IR_{\text{bin,new}} \cdot P_{\text{cat}}}{IR_{\text{original}}}$$
\end{column}

\begin{column}{0.48\textwidth}
\textbf{Case fatality pathway}

\medskip
\textit{Incremental coverage above baseline:}
$$\Delta C_{\delta}(t) = \max(C_t - C_0,\;0)$$

\textit{Aggregate across hypertensive bins ($\geq$140 mmHg):}
$$C_{\text{agg}}^{\Delta} = \frac{\sum_{\geq140}\Delta C_{\delta}\cdot P_{\text{cat}}}{\sum_{\geq140} P_{\text{cat}}}$$

\textit{CF effect ratio:}
$$\varepsilon_{CF} = 1 - \rho_{CF}\times C_{\text{agg}}^{\Delta}$$

\small
\begin{tabular}{@{}lc@{}}
\toprule Cause & $\rho_{CF}$ \\ \midrule
IHD & 0.24 \\ Ischemic stroke & 0.36 \\
Hemorrhagic stroke & 0.76 \\ HHD & 0.20 \\
\bottomrule
\end{tabular}
\end{column}
\end{columns}

# \textcolor{uwpurple}{Results}

## Baseline: CVD Trends Without Intervention

```{r baseline-trends, fig.height=3.0}
# Pre-computed by aim2_report.Rmd → aim2_slides_fig_baseline_trends.png
knitr::include_graphics(paste0(wd_outp, "aim2_slides_fig_baseline_trends.png"))
```

## Key Finding: Deaths Averted by Scenario, 2026--2050

```{r fig1-deaths-averted, fig.height=3.0}
# Pre-computed by aim2_report.Rmd → aim2_slides_fig1_deaths_averted.png
knitr::include_graphics(paste0(wd_outp, "aim2_slides_fig1_deaths_averted.png"))
```

## Summary Table: Deaths Averted, 2026--2050

```{r table1-summary}
# Pre-computed by aim2_report.Rmd → aim2_slides_tab1_summary.rds
kable(dt_sl_tab1[, .(
    Scenario                    = htn_scenario,
    `Deaths averted 2026--2050` = paste0(comma(deaths_M, accuracy = 0.01), " M"),
    `Per year (thousands)`      = comma(per_year_k, accuracy = 1),
    `\\% of BAU deaths`         = paste0(pct_bau, "\\%")
  )], align = "lrrr", escape = FALSE, booktabs = TRUE, format = "latex") |>
  kable_styling(latex_options = c("hold_position"),
                font_size = 10, full_width = FALSE, position = "center") |>
  column_spec(1, bold = TRUE, width = "3.5cm") |>
  column_spec(2:4, width = "3.2cm") |>
  row_spec(0, bold = TRUE, color = "white", background = "#2c3e50") |>
  row_spec(2, background = "#dbeafe", bold = TRUE)
```

\vspace{0.4em}
\begin{exampleblock}{Interpretation}
\small
The \textbf{Ambitious scenario is the policy headline}: accelerated scale-up toward WHO interim targets, underpinning the 150-million commitment. Every step up in ambition saves additional lives.
\end{exampleblock}

## Deaths Averted by Cause of Death

```{r fig2-by-cause, fig.height=3.1}
# Pre-computed by aim2_report.Rmd → aim2_slides_fig2_by_cause.png
knitr::include_graphics(paste0(wd_outp, "aim2_slides_fig2_by_cause.png"))
```

## When Do Benefits Arrive? Cumulative Deaths Averted

```{r fig-cumulative, fig.height=3.1}
# Pre-computed by aim2_report.Rmd → aim2_slides_fig_cumulative.png
knitr::include_graphics(paste0(wd_outp, "aim2_slides_fig_cumulative.png"))
```

\small\textit{Bold line = Ambitious (headline) scenario. Vertical lines mark start and end of scale-up.}

## Who Benefits? Deaths Averted by Age Group and Sex

```{r fig-age-sex, fig.height=3.0}
# Pre-computed by aim2_report.Rmd → aim2_slides_fig_age_sex.png
knitr::include_graphics(paste0(wd_outp, "aim2_slides_fig_age_sex.png"))
```

<!--## Where Are the Gains? Top 20 Countries (Ambitious)

```{r fig-top20, fig.height=3.4}
# Pre-computed by aim2_report.Rmd → aim2_slides_fig_top20.png
knitr::include_graphics(paste0(wd_outp, "aim2_slides_fig_top20.png"))
```
-->
## Regional Summary --- All Three Scenarios

```{r table5-region}
# Pre-computed by aim2_report.Rmd → aim2_slides_tab5_region.rds
dt_sl_tab5_fmt <- copy(dt_sl_tab5)
for (col in c("Progress", "Ambitious", "Aspirational"))
  if (col %in% names(dt_sl_tab5_fmt))
    dt_sl_tab5_fmt[, (col) := paste0(comma(round(get(col)/1e6, 2),
                                           accuracy = 0.01), " M")]
kable(dt_sl_tab5_fmt, align = c("l","r","r","r"),
      booktabs = TRUE, format = "latex",
      caption = "Deaths averted (millions) by region and scenario, 2026--2050") |>
  kable_styling(latex_options = c("hold_position","striped"),
                font_size = 9, full_width = TRUE) |>
  column_spec(1, bold = TRUE) |>
  column_spec(3, bold = TRUE, color = "#2171b5") |>
  row_spec(0, bold = TRUE, color = "black", background = "#2c3e50")
```

\vspace{0.2em}
\small\textit{Column highlighted in blue = Ambitious (headline) scenario.}

## Age-Standardised CVD Mortality Rate by Scenario

```{r fig-asmr, fig.height=3.0}
# Pre-computed by aim2_report.Rmd → aim2_slides_fig_asmr.png
knitr::include_graphics(paste0(wd_outp, "aim2_slides_fig_asmr.png"))
```

# \textcolor{uwpurple}{Discussion \& Limitations}

## Interpreting the Results

\begin{columns}[T]
\begin{column}{0.52\textwidth}
\textbf{What the numbers mean:}
\begin{itemize}\small
  \item Deaths averted = \textit{lives saved or meaningfully extended}, not merely deferred
  \item Benefits begin immediately after \textbf{2026} scale-up and compound over the 25-year horizon
  \item The \textbf{Ambitious--Progress gap} is the policy dividend of accelerating beyond current trends
  \item Geographic concentration: a few high-population countries drive global totals
\end{itemize}

\medskip
\textbf{Consistency with prior work:}
\begin{itemize}\small
  \item Direction consistent with Mills et al.\ 2020 \textit{(Circulation)} and NCD Countdown 2030 \textit{(Lancet, 2022)}
  \item Magnitude depends strongly on $C_0$: countries with lower baseline coverage gain more per unit coverage added
\end{itemize}
\end{column}

\begin{column}{0.45\textwidth}
\begin{block}{The Ambitious--Progress Gap}
\small
This difference quantifies the \textbf{additional lives saved by accelerating} beyond status-quo trends toward the WHO 150-million target. It is the core policy-relevant estimand of Aim 2.
\end{block}

\medskip
\begin{alertblock}{Questions for Decision-Makers}
\small
\begin{itemize}
  \item What investments move countries Progress $\to$ Ambitious?
  \item Which countries have the largest unmet coverage gap?
  \item How do these savings compare to the cost of inaction?
\end{itemize}
\end{alertblock}
\end{column}
\end{columns}

## Limitations

\begin{columns}[T]
\begin{column}{0.48\textwidth}
\textbf{Model structure}
\begin{itemize}\small
  \item Stable transition rates assumed; no dynamic feedback between states
  \item BP distributions log-normal and static --- no secular trend modelled
  \item COVID-19 excess mortality only 2020--2021; long-term effects excluded
\end{itemize}

\medskip
\textbf{Data \& parameters}
\begin{itemize}\small
  \item Ettehad $\rho_{CF}$ values from RCTs --- may overestimate real-world effectiveness at scale
  \item GBD 2023 uncertainty intervals not propagated
  \item Baseline $C_0$ from NCD-RisC; measurement error unquantified
\end{itemize}
\end{column}

\begin{column}{0.48\textwidth}
\textbf{Scenarios}
\begin{itemize}\small
  \item Linear 2026--2030 scale-up assumed; real programmes may differ
  \item No health-system capacity constraints modelled
  \item Interactions with statins, diabetes and \alert{BP device availability} not included in Aim 2; planned for Aim 1 combined scenario
\end{itemize}
\end{column}
\end{columns}

# \textcolor{uwpurple}{Next Steps}

## Recommendations and Next Steps

\begin{columns}[T]
\begin{column}{0.48\textwidth}
\textbf{Immediate analytical priorities:}
\begin{itemize}\small
  \item[$\square$] Calibration: WHO Global Health Estimates
  \item[$\square$] Sensitivity: 2019--2025 model trend vs.observed GBD 2023
  \item[$\square$] Burden of uncontrolled HTN: compute DALYs and YLLs
  \item[$\square$] Aim 1 combined-scenario
\end{itemize}

\end{column}
\begin{column}{0.48\textwidth}
\textbf{WHO briefing package:}
\begin{itemize}\small
  \item[$\square$] WHO-formatted summary table (Ambitious, all regions)
  \item[$\square$] Policy brief for WHO NCD team with headline numbers
  \item[$\square$] Aim 2 manuscript draft
\end{itemize}

\medskip
\begin{block}{Pending decision}
\small
Confirm \textbf{Ambitious} as the WHO reporting headline scenario and align country target values with the WHO 150-million denominator methodology.
\end{block}
\end{column}
\end{columns}

## Summary: The Case for Ambitious HTN Control

```{r summary-table-final}
sum_dt <- data.table(
  Metric=c(
    "Countries modelled",
    "Intervention period",
    "Scale-up window",
    "Progress --- deaths averted",
    "\\textbf{Ambitious --- deaths averted (headline)}",
    "Aspirational --- deaths averted",
    "Ambitious average per year",
    "Leading beneficiary cause"
  ),
  Value=c(
    as.character(n_countries),
    "2026--2050 (25 years)",
    "Linear, 2026 \\textrightarrow{} 2030",
    fmt_m(total_progress), " million",
    paste0("\\textbf{", fmt_m(total_ambitious), " million}"),
    fmt_m(total_aspirational), " million",
    paste0(fmt_k(total_ambitious / 25), " thousand / year"),
    "Ischemic heart disease"
  )
)
kable(sum_dt, col.names=c("Metric","Value"),
      align="lr", escape=FALSE, booktabs=TRUE, format="latex") |>
  kable_styling(latex_options=c("hold_position"),
                font_size=10, full_width=FALSE, position="center") |>
  column_spec(1, width="9cm") |>
  column_spec(2, width="4cm") |>
  row_spec(0, bold=TRUE, color="white", background="#2c3e50") |>
  row_spec(5, background="#dbeafe", bold=TRUE)
```

\vspace{0.3em}
\begin{exampleblock}{Bottom Line}
\small
Achieving the \textbf{Ambitious} HTN control scenario --- the WHO 150-million-target trajectory --- is one of the highest-return investments in global cardiovascular health. Scale-up starts \textbf{2026}; benefits compound to 2050.
\end{exampleblock}

# \textcolor{uwpurple}{Appendix}

## References

\small
\textbf{Ettehad D, et al.}\ Blood pressure lowering for prevention of CVD and death. \textit{Lancet.} 2016;387:957--967.

\medskip
\textbf{GBD 2023 Risk Factors Collaborators.}\ Global burden of 87 risk factors in 204 countries. \textit{Lancet.} 2024.

\medskip
\textbf{Mills KT, et al.}\ Global disparities of hypertension prevalence and control. \textit{Circulation.} 2016;134:441--450.

\medskip
\textbf{NCD Countdown 2030 Collaborators.}\ Pathways to achieving SDG target 3.4. \textit{Lancet.} 2022;399:1226--1249.

\medskip
\textbf{United Nations.}\ World Population Prospects 2024. UN DESA; 2024.

\medskip
\textbf{WHO.}\ HEARTS Technical Package. Geneva: WHO; 2018.

\medskip
\textbf{WHO.}\ Global NCD Political Declaration. Geneva: WHO; 2025.

## Mathematical Notation

```{r notation-table}
notation <- data.table(
  Symbol=c("$IR$, $CF$","$P(\\text{BP}_{\\text{cat}})$","$C_0$, $C_t$",
           "$\\Delta C^*$","$E_{\\text{trial}}$","$E_{\\text{adj}}$",
           "$\\alpha$","$\\varepsilon_{IR}$, $\\varepsilon_{CF}$",
           "$\\rho_{CF}$","$W$, $K$, $D$"),
  Description=c(
    "Incidence rate; case fatality rate (GBD-calibrated baseline)",
    "Probability distribution across 8 BP categories",
    "Baseline coverage and coverage at time $t$",
    "Incremental coverage needed to reach $C_{\\text{target}}$ above $C_0$",
    "Ettehad effect size (diabetes-weighted, per BP bin $\\times$ cause)",
    "Coverage-adjusted effect (accounts for pre-existing baseline treatment)",
    "Normalisation factor for GBD RR-weighted BP distribution",
    "Multiplicative effect ratios passed to state-transition model",
    "CF reduction factor per unit incremental coverage (cause-specific)",
    "Well, Sick, Dead population state counts"
  )
)
kable(notation, col.names=c("Symbol","Description"),
      escape=FALSE, booktabs=TRUE, format="latex") |>
  kable_styling(latex_options=c("striped","hold_position"),
                font_size=8, full_width=TRUE) |>
  column_spec(1, bold=TRUE, width="2.8cm") |>
  row_spec(0, bold=TRUE, color="white", background="#2171b5")
```

\vspace{1em}
\centering\small\textit{Generated: `r format(Sys.time(),"%d %B %Y")` $\cdot$ R `r R.version$major`.`r R.version$minor` $\cdot$ University of Washington}
